Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma

Leukemia

Volumn 27, Issue 3, 2013, Pages 671-679

  Bohle, V ^a   Doring C ^b   Hansmann, M L ^b   Kuppers R ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

B cell phenotype; CD19; CD79; EBF1; Hodgkin lymphoma

Indexed keywords

B CELL FACTOR 1; CD19 ANTIGEN; CD79A ANTIGEN; CD79B ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HODGKIN DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; B-LYMPHOCYTES; BASE SEQUENCE; BLOTTING, WESTERN; CELL PROLIFERATION; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HODGKIN DISEASE; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REED-STERNBERG CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875215037     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.280     Document Type: Article

References (50)

1. Kü ppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 1994; 91: 10962-10966.
2. Mü schen M, Rajewsky K, Bräuninger A, Baur AS, Oudejans JJ, Roers A et al. Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J Exp Med 2000; 191: 387-394.
3. Kanzler H, Kü ppers R, Hansmann ML, Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184: 1495-1505.
4. Schwering I, Bräuninger A, Klein U, Jungnickel B, Tinguely M, Diehl V et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2003; 101: 1505-1512.
5. Watanabe K, Yamashita Y, Nakayama A, Hasegawa Y, Kojima H, Nagasawa T et al. Varied B-cell immunophenotypes of Hodgkin/Reed-Sternberg cells in classic Hodgkin's disease. Histopathology 2000; 36: 353-361.
6. Stein H, Marafioti T, Foss HD, Laumen H, Hummel M, Anagnostopoulos I et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 2001; 97: 496-501.
7. Re D, Muschen M, Ahmadi T, Wickenhauser C, Staratschek-Jox A, Holtick U et al. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. Cancer Res 2001; 61: 2080-2084.
8. van den Berg A, Visser L, Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am J Pathol 1999; 154: 1685-1691.
9. Kü ppers R, Klein U, Schwering I, Distler V, Bräuninger A, Cattoretti G et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest 2003; 111: 529-537.
10. Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H, Dorken B. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 2002; 99: 3398-3403.
11. Mathas S, Janz M, Hummel F, Hummel M, Wollert-Wulf B, Lusatis S et al. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol 2006; 7: 207-215.
12. Renne C, Martin-Subero JI, Eickernjager M, Hansmann ML, Kü ppers R, Siebert R et al. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma. Am J Pathol 2006; 169: 655-664.
13. Küppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer 2009; 9: 15-27.
14. Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R et al. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol 2010; 11: 635-643.
15. Pongubala JM, Northrup DL, Lancki DW, Medina KL, Treiber T, Bertolino E et al. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat Immunol 2008; 9: 203-215.
16. Treiber T, Mandel EM, Pott S, Gyory I, Firner S, Liu ET et al. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcriptionindependent poising of chromatin. Immunity 2010; 32: 714-725.
17. Maier H, Ostraat R, Gao H, Fields S, Shinton SA, Medina KL et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat Immunol 2004; 5: 1069-1077.
18. Vilagos B, Hoffmann M, Souabni A, Sun Q, Werner B, Medvedovic J et al. Essential role of EBF1 in the generation and function of distinct mature B cell types. J Exp Med 2012; 209: 775-792.
19. Gyö ry I, Boller S, Nechanitzky R, Mandel E, Pott S, Liu E et al. Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. Genes Dev 2012; 26: 668-682.
20. Hertel CB, Zhou XG, Hamilton-Dutoit SJ, Junker S. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene 2002; 21: 4908-4920.
21. Krenacs L, Himmelmann AW, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A et al. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. Blood 1998; 92: 1308-1316.
22. Foss HD, Reusch R, Demel G, Lenz G, Anagnostopoulos I, Hummel M et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood 1999; 94: 3108-3113.
23. Tiacci E, Dö ring C, Brune V, van Noesel CJ, Klapper W, Mechtersheimer G et al. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. Blood 2012, ealy online Sept. 5. PMID: 22955914.
24. Jundt F, Acikgoz O, Kwon SH, Schwarzer R, Anagnostopoulos I, Wiesner B et al. Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma. Leukemia 2008; 22: 1587-1594.
25. Doerr JR, Malone CS, Fike FM, Gordon MS, Soghomonian SV, Thomas RK et al. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines. J Mol Biol 2005; 350: 631-640.
26. Ushmorov A, Leithauser F, Sakk O, Weinhausel A, Popov SW, Moller P et al. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma. Blood 2006; 107: 2493-2500.
27. Ammerpohl O, Haake A, Pellissery S, Giefing M, Richter J, Balint B et al. Arraybased DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes. Leukemia 2012; 26: 185-188.
28. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18: 1427-1431.
29. Lutsik P, Feuerbach L, Arand J, Lengauer T, Walter J, Bock C. BiQ Analyzer HT: locus-specific analysis of DNA methylation by high-throughput bisulfite sequencing. Nucleic Acids Res 2011; 39(Web Server issue): W551-W556.
30. Zandi S, Mansson R, Tsapogas P, Zetterblad J, Bryder D, Sigvardsson M. EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors. J Immunol 2008; 181: 3364-3372.
31. Ushmorov A, Ritz O, Hummel M, Leithauser F, Moller P, Stein H et al. Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood 2004; 104: 3326-3334.
32. Lowder M, Unge A, Maraha N, Jansson JK, Swiggett J, Oliver JD. Effect of starvation and the viable-but-nonculturable state on green fluorescent protein (GFP) fluorescence in GFP-tagged Pseudomonas fluorescens A506. Appl Environ Microbiol 2000; 66: 3160-3165.
33. Küppers R, Bräuninger A. Reprogramming of the tumour B-cell phenotype in Hodgkin lymphoma. Trends Immunol 2006; 27: 203-205.
34. Leduc I, Cogne M. Regulatory elements of the mb-1 gene encoding the Ig-alpha component of the human B-cell antigen receptor. Mol Immunol 1996; 33: 1277-12786.
35. Akerblad P, Rosberg M, Leanderson T, Sigvardsson M. The B29 (immunoglobulin beta-chain) gene is a genetic target for early B-cell factor. Mol Cell Biol 1999; 19: 392-401.
36. Thompson AA, Wood Jr. WJ, Gilly MJ, Damore MA, Omori SA, Wall R. The promoter and 50 flanking sequences controlling human B29 gene expression. Blood 1996; 87: 666-673.
37. Decker T, Pasca di Magliano M, McManus S, Sun Q, Bonifer C, Tagoh H et al. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis. Immunity 2009; 30: 508-520.
38. Hirokawa S, Sato H, Kato I, Kudo A. EBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B cells. Eur J Immunol 2003; 33: 1824-1829.
39. Yoon SO, Zhang X, Berner P, Blom B, Choi YS. Notch ligands expressed by follicular dendritic cells protect germinal center B cells from apoptosis. J Immunol 2009; 183: 352-358.
40. Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymphoma 1992; 8: 283-313.
41. Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. Leuk Lymphoma 1993; 9: 1-25.
42. Schaniel C, Pardali E, Sallusto F, Speletas M, Ruedl C, Shimizu T et al. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J Exp Med 1998; 188: 451-463.
43. Maggio EM, Van Den Berg A, Visser L, Diepstra A, Kluiver J, Emmens R et al. Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical Hodgkin lymphomas. Int J Cancer 2002; 99: 665-672.
44. Poppema S. Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology Am Soc Hematol Educ Program 2005 231-238.
45. Suzuki K, Okuno T, Yamamoto M, Pasterkamp RJ, Takegahara N, Takamatsu H et al. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature 2007; 446: 680-684.
46. Angel CA, Warford A, Campbell AC, Pringle JH, Lauder I. The immunohistology of Hodgkin's disease-Reed-Sternberg cells and their variants. J Pathol 1987; 153: 21-30.
47. Jarrett RF, Armstrong A, Wilkins BS, Jones DB. Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections. J Pathol 1991; 164: 345-346.
48. Salama ME, Rajan Mariappan M, Inamdar K, Tripp SR, Perkins SL. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma. Int J Surg Pathol 2010; 18: 121-128.
49. Rowlands DC, Hansel TT, Crocker J. Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections. J Pathol 1990; 160: 239-243.
50. Pandey A, Ozaki K, Baumann H, Levin SD, Puel A, Farr AG et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol 2000; 1: 59-64.